Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof
US11155558B2 · kind B2 · utility
0Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 2018 |
| Grant date | Oct 26, 2021 |
| Priority date | — |
| Expiry date | May 22, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula I or pharmaceutically acceptable salt, solvate or hydrate thereof, wherein
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.